Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials

Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials

Background: Ranolazine has the potential to prevent atrial fibrillation (AF) and plays a role in rhythm control strategy for atrial fibrillation in various clinical settings. However, data on the use of ranolazine in patients with left ventricular (LV) systolic dysfunction are limited. The aims of t...

Full description

Bibliographic Details
Main Authors: Pattranee Leelapatana, Charat Thongprayoon, Narut Prasitlumkum, Saraschandra Vallabhajosyula, Wisit Cheungpasitporn, Ronpichai Chokesuwattanaskul
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Diseases
Subjects:
atrial fibrillation
ranolazine
systolic dysfunction
heart failure
meta-analysis
Online Access:https://www.mdpi.com/2079-9721/9/2/31

Similar Items

Similar Items